Corteva, Inc. CTVA
11.88 USD -0.04 (-0.34%)
At closeNov 4, 2026, 4:00 AM EST
11.81 -0.07 -0.62%
Pre-market · Nov 4, 4:00 AM ET
11.72 Day range 12.03
9.19 52-week range 14.62
- YTD
- +18.09%
- 1 year
- +27.60%
Analyst view
Consensus: buy
Buy
Price target (mean) 17.13 +44.2% upside
Now 11.88
- Target (low)
- 13.65
- Target (mean)
- 17.13
- Target (high)
- 20.00
Ratings (0m) 13 11 buy · 2 hold · 0 sell
- Strong buy3
- Buy8
- Hold2
- Sell0
- Strong sell0
Recommendation trend
- This month 13
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.09571 | 0.00 – 0.1809 | 0.00 | 0.0% | 1.77B | 0.0% | 6 |
| Next quarter | 0.2576 | 0.22 – 0.32003 | 0.00 | 0.0% | 2.31B | 0.0% | 5 |
| Current year | 1.07 | 0.64774 – 1.96 | 0.00 | 0.0% | 7.81B | 0.0% | 8 |
| Next year | 1.12 | 0.85262 – 1.42 | 1.07 | +4.7% | 8.06B | +3.1% | 9 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 12, 2026 | UBS | Maintained | Neutral | Neutral |
| Oct 7, 2026 | Keybanc | Upgrade | Sector Weight | Overweight |
| Oct 6, 2026 | JP Morgan | Upgrade | Neutral | Overweight |
| Sep 18, 2026 | Argus Research | Reiterated | Buy | Buy |
| Sep 17, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Sep 16, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Sep 16, 2026 | UBS | Maintained | Neutral | Neutral |
| Sep 16, 2026 | RBC Capital | Reiterated | Outperform | Outperform |
| Sep 11, 2026 | Keybanc | Initiated | — | Sector Weight |
| Aug 18, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 3, 2026 | UBS | Maintained | Neutral | Neutral |
| Aug 3, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Aug 3, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Aug 3, 2026 | BMO Capital | Maintained | Outperform | Outperform |
| Jul 23, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Jul 21, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 20, 2026 | B of A Securities | Maintained | Buy | Buy |
| Jul 14, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jul 2, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Jun 11, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jun 9, 2026 | UBS | Maintained | Neutral | Neutral |
| May 28, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| May 7, 2026 | UBS | Maintained | Neutral | Neutral |
| May 7, 2026 | Citigroup | Maintained | Neutral | Neutral |
| Apr 24, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Apr 22, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Apr 21, 2026 | Wells Fargo | Maintained | Overweight | Overweight |
| Apr 9, 2026 | UBS | Maintained | Neutral | Neutral |
| Mar 31, 2026 | Argus Research | Maintained | Buy | Buy |
| Feb 17, 2026 | Mizuho | Maintained | Outperform | Outperform |
